R > Female Aged | BibSonomy

publications (hide)45
display
all
publications only
publications per page
5
10
20
50
100
sort by
added at
title
author
publication date
entry type
help for advanced sorting...
RSS
BibTeX
RDF
more...

1Potential bias in pharmacoepidemiological studies due to the length of the drug free period: a study on antidepressant drug use in adults in the Netherlands.
H. Gardarsdottir, E. Heerdink, and A. Egberts. Pharmacoepidemiology and drug safety, 15 (5): 338-43 (May 2006)4368 PUBM: Print; JID: 9208369; 0 (Antidepressive Agents); ppublish; Mesures de freqüència.
2 years ago by @jepcastel
show all tags
Pharmacoepidemiology:methods
Humans
Male
Incidence
AntidepressiveAgents
AntidepressiveAgents:administration&dosage
TimeFactors
Pharmacoepidemiology
Adolescent
Adult
Bias(Epidemiology)
CohortStudies
Aged
Female
MiddleAged
Pharmacoepidemiology:methodsHumansMaleIncidenceAntidepressiveAgentsAntidepressiveAgents:administration&dosageTimeFactorsPharmacoepidemiologyAdolescentAdultBias(Epidemiology)CohortStudiesAgedFemaleMiddleAged
copydeleteadd this publication to your clipboard
1Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study.
G. Albers, V. Bates, W. Clark, R. Bell, P. Verro, and S. Hamilton. JAMA : the journal of the American Medical Association, 283 (9): 1145-50 (March 2000)2783.
2 years ago by @jepcastel
show all tags
TissuePlasminogenActivator
ThrombolyticTherapy
Intravenous
Infusions
80andover
SurvivalAnalysis
TissuePlasminogenActivator:administration&dos
Stroke
PlasminogenActivators
CerebralHemorrhage:prevention&control
Stroke:physiopathology
Aged
Humans
TissuePlasminogenActivator:therapeuticuse
Male
ProspectiveStudies
MultivariateAnalysis
Stroke:diagnosis
SeverityofIllnessIndex
TimeFactors
PlasminogenActivators:therapeuticuse
PlasminogenActivators:administration&dosage
Adult
CerebralHemorrhage
Stroke:drugtherapy
TreatmentOutcome
Female
MiddleAged
TissuePlasminogenActivatorThrombolyticTherapyIntravenousInfusions80andoverSurvivalAnalysisTissuePlasminogenActivator:administration&dosStrokePlasminogenActivatorsCerebralHemorrhage:prevention&controlStroke:physiopathologyAgedHumansTissuePlasminogenActivator:therapeuticuseMaleProspectiveStudiesMultivariateAnalysisStroke:diagnosisSeverityofIllnessIndexTimeFactorsPlasminogenActivators:therapeuticusePlasminogenActivators:administration&dosageAdultCerebralHemorrhageStroke:drugtherapyTreatmentOutcomeFemaleMiddleAged
copydeleteadd this publication to your clipboard
1Methods for constructing and assessing propensity scores.
M. Garrido, A. Kelley, J. Paris, K. Roza, D. Meier, R. Morrison, and M. Aldridge. Health services research, 49 (5): 1701-20 (October 2014)Propensity score; STATA; Introductori; Anàlisi de dades.
2 years ago by @jepcastel
show all tags
PalliativeCare:statistics&numericaldata
ResearchDesign
80andover
Neoplasms:epidemiology
OutcomeAssessment(HealthCare):methods
DataInterpretation
Pennsylvania
YoungAdult
Statistical
Models
ConfoundingFactors(Epidemiology)
Aged
Ohio
Virginia
CancerCareFacilities:statistics&numericaldat
Humans
PropensityScore
Male
Neoplasms
OutcomeAssessment(HealthCare)
PalliativeCare
CancerCareFacilities
NewYork
Adult
TreatmentOutcome
Female
MiddleAged
Wisconsin
PalliativeCare:statistics&numericaldataResearchDesign80andoverNeoplasms:epidemiologyOutcomeAssessment(HealthCare):methodsDataInterpretationPennsylvaniaYoungAdultStatisticalModelsConfoundingFactors(Epidemiology)AgedOhioVirginiaCancerCareFacilities:statistics&numericaldatHumansPropensityScoreMaleNeoplasmsOutcomeAssessment(HealthCare)PalliativeCareCancerCareFacilitiesNewYorkAdultTreatmentOutcomeFemaleMiddleAgedWisconsin
copydeleteadd this publication to your clipboard
1Nonaspirin NSAIDs, cyclooxygenase 2 inhibitors, and the risk for stroke.
C. Roumie, E. Mitchel, L. Kaltenbach, P. Arbogast, P. Gideon, and M. Griffin. Stroke; a journal of cerebral circulation, 39 (7): 2037-45 (July 2008)4450<m:linebreak></m:linebreak>PUBM: Print-Electronic; JID: 0235266; 0 (Anti-Inflammatory Agents, Non-Steroidal); 0 (Cyclooxygenase 2 Inhibitors); 2008/04/24 aheadofprint; ppublish;<m:linebreak></m:linebreak>New-user designs.
2 years ago by @jepcastel
show all tags
Cyclooxygenase2Inhibitors
Anti-InflammatoryAgents
CardiovascularDiseases:chemicallyinduced
80andover
CardiovascularDiseases:prevention&control
Non-Steroidal
Humans
Male
Risk
Stroke
RetrospectiveStudies
Stroke:etiology
RiskFactors
Non-Steroidal:pharmacology
Stroke:chemicallyinduced
Cyclooxygenase2Inhibitors:pharmacology
CohortStudies
Aged
Female
Stroke:prevention&control
CardiovascularDiseases
MiddleAged
Cyclooxygenase2InhibitorsAnti-InflammatoryAgentsCardiovascularDiseases:chemicallyinduced80andoverCardiovascularDiseases:prevention&controlNon-SteroidalHumansMaleRiskStrokeRetrospectiveStudiesStroke:etiologyRiskFactorsNon-Steroidal:pharmacologyStroke:chemicallyinducedCyclooxygenase2Inhibitors:pharmacologyCohortStudiesAgedFemaleStroke:prevention&controlCardiovascularDiseasesMiddleAged
copydeleteadd this publication to your clipboard
1Mortality from tobacco in developed countries: indirect estimation from national vital statistics.
R. Peto, A. Lopez, J. Boreham, M. Thun, and C. Heath. Lancet, 339 (8804): 1268-78 (May 1992)4321<m:linebreak></m:linebreak>LR: 20041117; PUBM: Print; JID: 2985213R; CIN: Lancet. 1992 Jul 11;340(8811):121. PMID: 1351994; CIN: Lancet. 1992 Jun 13;339(8807):1484. PMID: 1351160; CIN: Lancet. 1992 Jun 13;339(8807):1484. PMID: 1351161; CIN: Lancet. 1992 Sep 12;340(8820):666. PMID: 1355221; CIN: Lancet. 1992 Sep 12;340(8820):666-8. PMID: 1355222; ppublish;<m:linebreak></m:linebreak>Risc atribuïble.
2 years ago by @jepcastel
show all tags
Neoplasms:mortality
80andover
Europe
LungDiseases:mortality
LifeExpectancy
PopulationSurveillance
LungDiseases
DataInterpretation
Smoking
Statistical
Aged
UnitedStates
UnitedStates:epidemiology
Europe:epidemiology
Humans
Male
Risk
Neoplasms
ProspectiveStudies
Smoking:mortality
Adult
Smoking:adverseeffects
Female
CardiovascularDiseases:mortality
CardiovascularDiseases
MiddleAged
Neoplasms:mortality80andoverEuropeLungDiseases:mortalityLifeExpectancyPopulationSurveillanceLungDiseasesDataInterpretationSmokingStatisticalAgedUnitedStatesUnitedStates:epidemiologyEurope:epidemiologyHumansMaleRiskNeoplasmsProspectiveStudiesSmoking:mortalityAdultSmoking:adverseeffectsFemaleCardiovascularDiseases:mortalityCardiovascularDiseasesMiddleAged
copydeleteadd this publication to your clipboard
1A comparison of two methods for estimating odds ratios: results from the National Health Survey.
E. Bakhshi, M. Eshraghian, K. Mohammad, and B. Seifi. BMC medical research methodology, (January 2008)5162<m:linebreak></m:linebreak>JID: 100968545; OID: NLM: PMC2613917; 2008/07/06 received; 2008/11/25 accepted; 2008/11/25 aheadofprint; epublish;.
2 years ago by @jepcastel
show all tags
Obesity
EducationalStatus
HealthSurveys
Humans
LogisticModels
Obesity:epidemiology
ConfidenceIntervals
OddsRatio
Smoking
Adult
Aged
Female
Marriage
BodyMassIndex
MiddleAged
ObesityEducationalStatusHealthSurveysHumansLogisticModelsObesity:epidemiologyConfidenceIntervalsOddsRatioSmokingAdultAgedFemaleMarriageBodyMassIndexMiddleAged
copydeleteadd this publication to your clipboard
1The impact of analytic method on interpretation of outcomes in longitudinal clinical trials.
A. Prakash, R. Risser, and C. Mallinckrodt. International journal of clinical practice, 62 (8): 1147-58 (August 2008)4738 ClinicalTrials.gov/NCT00073411; JID: 9712381; 0 (Adrenergic Uptake Inhibitors); 0 (Serotonin Uptake Inhibitors); 2008/06/28 aheadofprint; ppublish; Dades censurades; RCT; Dades longitudinals.
2 years ago by @jepcastel
show all tags
DataCollection:methods
RCT
SerotoninUptakeInhibitors:therapeuticuse
Humans
LongitudinalStudies
Male
AdrenergicUptakeInhibitors
DataInterpretation
AdrenergicUptakeInhibitors:therapeuticuse
SerotoninUptakeInhibitors
Double-BlindMethod
SampleSize
Adolescent
DepressiveDisorder:drugtherapy
Statistical
DataCollection
Adult
Aged
DepressiveDisorder
TreatmentOutcome
Female
AmbulatoryCare
MiddleAged
DataCollection:methodsRCTSerotoninUptakeInhibitors:therapeuticuseHumansLongitudinalStudiesMaleAdrenergicUptakeInhibitorsDataInterpretationAdrenergicUptakeInhibitors:therapeuticuseSerotoninUptakeInhibitorsDouble-BlindMethodSampleSizeAdolescentDepressiveDisorder:drugtherapyStatisticalDataCollectionAdultAgedDepressiveDisorderTreatmentOutcomeFemaleAmbulatoryCareMiddleAged
copydeleteadd this publication to your clipboard
1Calendar time-specific propensity scores and comparative effectiveness research for stage III colon cancer chemotherapy.
C. Mack, R. Glynn, M. Brookhart, W. Carpenter, A. Meyer, R. Sandler, and T. Stürmer. Pharmacoepidemiology and drug safety, 22 (8): 810-8 (August 2013)Propensity score; Oncologia.
2 years ago by @jepcastel
show all tags
Antineoplastic:therapeuticuse
AntineoplasticAgents
80andover
OrganoplatinumCompounds:administration&dosage
Antineoplastic
Medicare
Antineoplastic:administration&dosage
OrganoplatinumCompounds:therapeuticuse
Antimetabolites
ColonicNeoplasms
OrganoplatinumCompounds
ComparativeEffectivenessResearch
Aged
ColonicNeoplasms:pathology
UnitedStates
ColonicNeoplasms:drugtherapy
Humans
Fluorouracil:administration&dosage
PropensityScore
Male
LogisticModels
ProportionalHazardsModels
TimeFactors
AntineoplasticAgents:therapeuticuse
Registries
Fluorouracil:therapeuticuse
NeoplasmStaging
Female
Fluorouracil
Antineoplastic:therapeuticuseAntineoplasticAgents80andoverOrganoplatinumCompounds:administration&dosageAntineoplasticMedicareAntineoplastic:administration&dosageOrganoplatinumCompounds:therapeuticuseAntimetabolitesColonicNeoplasmsOrganoplatinumCompoundsComparativeEffectivenessResearchAgedColonicNeoplasms:pathologyUnitedStatesColonicNeoplasms:drugtherapyHumansFluorouracil:administration&dosagePropensityScoreMaleLogisticModelsProportionalHazardsModelsTimeFactorsAntineoplasticAgents:therapeuticuseRegistriesFluorouracil:therapeuticuseNeoplasmStagingFemaleFluorouracil
copydeleteadd this publication to your clipboard
1Size matters: just how big is BIG?: Quantifying realistic sample size requirements for human genome epidemiology.
P. Burton, A. Hansell, I. Fortier, T. Manolio, M. Khoury, J. Little, and P. Elliott. International journal of epidemiology, 38 (1): 263-73 (February 2009)4935<m:linebreak></m:linebreak>GR: 075883/Wellcome Trust/United Kingdom; GR: G9806740/Medical Research Council/United Kingdom; JID: 7802871; CIN: Int J Epidemiol. 2009 Feb;38(1):274-5. PMID: 18984600; OID: NLM: PMC2639365; 2008/08/01 aheadofprint; 2008/08/25 aheadofprint; ppublish;<m:linebreak></m:linebreak>Epidemiologia genètica.
2 years ago by @jepcastel
show all tags
Disease
ResearchDesign
Humans
ChronicDisease:epidemiology
Genomics
Male
Genomics:methods
ChronicDisease
SampleSize
Case-ControlStudies
BiologicalSpecimenBanks
Disease:genetics
GeneticPredispositiontoDisease
Adult
Aged
LifeStyle
Female
MiddleAged
DiseaseResearchDesignHumansChronicDisease:epidemiologyGenomicsMaleGenomics:methodsChronicDiseaseSampleSizeCase-ControlStudiesBiologicalSpecimenBanksDisease:geneticsGeneticPredispositiontoDiseaseAdultAgedLifeStyleFemaleMiddleAged
copydeleteadd this publication to your clipboard
1Multiple imputation using chained equations: Issues and guidance for practice.
I. White, P. Royston, and A. Wood. Statistics in medicine, 30 (4): 377-99 (February 2011)Dades censurades; Imputació múltiple.
2 years ago by @jepcastel
show all tags
CardiovascularDiseases:epidemiology
MentalHealth
Humans
Cholesterol
HDL
YoungAdult
Adolescent
Lipoproteins
HDL:blood
Statistical
Models
MentalHealth:statistics&numericaldata
Adult
MulticenterStudiesasTopic
Aged
Female
CardiovascularDiseases
Cholesterol:blood
MiddleAged
CardiovascularDiseases:epidemiologyMentalHealthHumansCholesterolHDLYoungAdultAdolescentLipoproteinsHDL:bloodStatisticalModelsMentalHealth:statistics&numericaldataAdultMulticenterStudiesasTopicAgedFemaleCardiovascularDiseasesCholesterol:bloodMiddleAged
copydeleteadd this publication to your clipboard
1Interpreting treatment effects from clinical trials in the context of real-world risk information: end-stage renal disease prevention in older adults.
A. O'Hare, J. Hotchkiss, M. Tamura, E. Larson, B. Hemmelgarn, A. Batten, T. Do, and K. Covinsky. JAMA internal medicine, 174 (3): 391-7 (March 2014)Generalització; Exemple; Nefrologia.
2 years ago by @jepcastel
show all tags
Chronic:prevention&control
Angiotensin-ConvertingEnzymeInhibitors:pharmaco
Angiotensin-ConvertingEnzymeInhibitors:therapeu
80andover
Humans
Male
OutcomeAssessment(HealthCare)
GlomerularFiltrationRate
KidneyFailure
ComputerSimulation
RetrospectiveStudies
Chronic
RiskFactors
Chronic:drugtherapy
GlomerularFiltrationRate:drugeffects
Aged
ClinicalTrialsasTopic
Angiotensin-ConvertingEnzymeInhibitors
Female
UnitedStates
Chronic:prevention&controlAngiotensin-ConvertingEnzymeInhibitors:pharmacoAngiotensin-ConvertingEnzymeInhibitors:therapeu80andoverHumansMaleOutcomeAssessment(HealthCare)GlomerularFiltrationRateKidneyFailureComputerSimulationRetrospectiveStudiesChronicRiskFactorsChronic:drugtherapyGlomerularFiltrationRate:drugeffectsAgedClinicalTrialsasTopicAngiotensin-ConvertingEnzymeInhibitorsFemaleUnitedStates
copydeleteadd this publication to your clipboard
1Confounding by contraindication in a nationwide cohort study of risk for death in patients taking ibopamine.
H. Feenstra, R. Grobbee, B. in't Veld, and B. Stricker. Annals of internal medicine, 134 (7): 569-72 (April 2001)Depleció de susceptibles.
2 years ago by @jepcastel
show all tags
AnalysisofVariance
HeartFailure:mortality
Deoxyepinephrine
80andover
Humans
Deoxyepinephrine:contraindications
Male
Questionnaires
RetrospectiveStudies
Deoxyepinephrine:analogs&derivatives
DopamineAgonists:contraindications
RiskFactors
HeartFailure
Deoxyepinephrine:therapeuticuse
ConfoundingFactors(Epidemiology)
DopamineAgonists
HeartFailure:drugtherapy
CohortStudies
Aged
DopamineAgonists:therapeuticuse
Female
MiddleAged
AnalysisofVarianceHeartFailure:mortalityDeoxyepinephrine80andoverHumansDeoxyepinephrine:contraindicationsMaleQuestionnairesRetrospectiveStudiesDeoxyepinephrine:analogs&derivativesDopamineAgonists:contraindicationsRiskFactorsHeartFailureDeoxyepinephrine:therapeuticuseConfoundingFactors(Epidemiology)DopamineAgonistsHeartFailure:drugtherapyCohortStudiesAgedDopamineAgonists:therapeuticuseFemaleMiddleAged
copydeleteadd this publication to your clipboard
1Polymorphisms in BRCA2 resulting in aberrant codon-usage and their analysis on familial breast cancer risk
R. Yang, B. Chen, K. Hemminki, B. Wappenschmidt, C. Engel, C. Sutter, N. Ditsch, Weber, Bernhard H F, D. Niederacher, N. Arnold and 4 other author(s). Breast cancer research and treatment, 118 (2): 407–413 (2009)
10 years ago by @drtester
show all tags
Middle_Aged
Humans
Genotype
Polymorphism,_Single_Nucleotide
Genetic_Predisposition_to_Disease
Aged,_80_and_over
Young_Adult
Codon
Adolescent
Case-Control_Studies
Breast_Neoplasms/genetics
Genes,_BRCA2
Adult
Genes,_BRCA1
Aged
Female
Middle_AgedHumansGenotypePolymorphism,_Single_NucleotideGenetic_Predisposition_to_DiseaseAged,_80_and_overYoung_AdultCodonAdolescentCase-Control_StudiesBreast_Neoplasms/geneticsGenes,_BRCA2AdultGenes,_BRCA1AgedFemale
copydeleteadd this publication to your clipboard
1Expanded extracolonic tumor spectrum in MUTYH-associated polyposis
S. Vogt, N. Jones, D. Christian, C. Engel, M. Nielsen, A. Kaufmann, V. Steinke, H. Vasen, P. Propping, J. Sampson and 2 other author(s). Gastroenterology, 137 (6): 1976-85.e1-10 (2009)
10 years ago by @drtester
show all tags
Risk_Factors
Retrospective_Studies
Risk_Assessment
Gastrointestinal_Neoplasms/epidemiology/genetics/pathology
Genetic_Predisposition_to_Disease
Young_Adult
Adolescent
Sebaceous_Gland_Neoplasms/epidemiology/genetics/pathology
Aged
Phenotype
Adenomatous_Polyposis_Coli/epidemiology/genetics/pathology
DNA_Glycosylases/genetics
Age_of_Onset
Middle_Aged
Kaplan-Meier_Estimate
Breast_Neoplasms/epidemiology/genetics/pathology
Humans
Ovarian_Neoplasms/epidemiology/genetics/pathology
Male
Incidence
Urinary_Bladder_Neoplasms/epidemiology/genetics/pathology
Europe/epidemiology
Adult
Child
Skin_Neoplasms/epidemiology/genetics/pathology
Endoscopy
Female
Risk_FactorsRetrospective_StudiesRisk_AssessmentGastrointestinal_Neoplasms/epidemiology/genetics/pathologyGenetic_Predisposition_to_DiseaseYoung_AdultAdolescentSebaceous_Gland_Neoplasms/epidemiology/genetics/pathologyAgedPhenotypeAdenomatous_Polyposis_Coli/epidemiology/genetics/pathologyDNA_Glycosylases/geneticsAge_of_OnsetMiddle_AgedKaplan-Meier_EstimateBreast_Neoplasms/epidemiology/genetics/pathologyHumansOvarian_Neoplasms/epidemiology/genetics/pathologyMaleIncidenceUrinary_Bladder_Neoplasms/epidemiology/genetics/pathologyEurope/epidemiologyAdultChildSkin_Neoplasms/epidemiology/genetics/pathologyEndoscopyFemale
copydeleteadd this publication to your clipboard
1Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers
A. Antoniou, A. Spurdle, O. Sinilnikova, S. Healey, K. Pooley, R. Schmutzler, B. Versmold, C. Engel, A. Meindl, N. Arnold and 76 other author(s). American journal of human genetics, 82 (4): 937–948 (2008)
10 years ago by @drtester
show all tags
Middle_Aged
Humans
Risk
Polymorphism,_Single_Nucleotide
Germ-Line_Mutation
MAP_Kinase_Kinase_Kinase_1/genetics
Receptor,_Fibroblast_Growth_Factor,_Type_2/genetics
Genetic_Predisposition_to_Disease/genetics
Breast_Neoplasms/genetics
Genes,_BRCA2
Adult
Genes,_BRCA1
Aged
Female
Middle_AgedHumansRiskPolymorphism,_Single_NucleotideGerm-Line_MutationMAP_Kinase_Kinase_Kinase_1/geneticsReceptor,_Fibroblast_Growth_Factor,_Type_2/geneticsGenetic_Predisposition_to_Disease/geneticsBreast_Neoplasms/geneticsGenes,_BRCA2AdultGenes,_BRCA1AgedFemale
copydeleteadd this publication to your clipboard
1Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers
L. Walker, Z. Fredericksen, X. Wang, R. Tarrell, V. Pankratz, N. Lindor, J. Beesley, S. Healey, X. Chen, D. Stoppa-Lyonnet and 63 other author(s). Breast cancer research : BCR, 12 (6): R102 (2010)
10 years ago by @drtester
show all tags
Middle_Aged
Signal_Transduction
Transforming_Growth_Factor_beta/genetics
Humans
Gene_Expression
Polymorphism,_Single_Nucleotide
Risk_Factors
Genome-Wide_Association_Study
Genetic_Predisposition_to_Disease
Aged,_80_and_over
Linkage_Disequilibrium
Breast_Neoplasms/genetics
Genes,_BRCA2
Adult
Mutation
Aged
Smad3_Protein/genetics
Female
Middle_AgedSignal_TransductionTransforming_Growth_Factor_beta/geneticsHumansGene_ExpressionPolymorphism,_Single_NucleotideRisk_FactorsGenome-Wide_Association_StudyGenetic_Predisposition_to_DiseaseAged,_80_and_overLinkage_DisequilibriumBreast_Neoplasms/geneticsGenes,_BRCA2AdultMutationAgedSmad3_Protein/geneticsFemale
copydeleteadd this publication to your clipboard
1Identification of a DMBT1 polymorphism associated with increased breast cancer risk and decreased promoter activity
S. Tchatchou, A. Riedel, S. Lyer, J. Schmutzhard, O. Strobel-Freidekind, S. Gronert-Sum, C. Mietag, M. D'Amato, B. Schlehe, K. Hemminki and 17 other author(s). Human mutation, 31 (1): 60–66 (2010)
10 years ago by @drtester
show all tags
Middle_Aged
Humans
Male
Breast_Neoplasms,_Male/genetics
Risk_Factors
Polymorphism,_Single_Nucleotide/genetics
Genetic_Predisposition_to_Disease
Case-Control_Studies
Breast_Neoplasms/genetics
Adult
Aged
Receptors,_Cell_Surface/genetics
Female
Promoter_Regions,_Genetic
Middle_AgedHumansMaleBreast_Neoplasms,_Male/geneticsRisk_FactorsPolymorphism,_Single_Nucleotide/geneticsGenetic_Predisposition_to_DiseaseCase-Control_StudiesBreast_Neoplasms/geneticsAdultAgedReceptors,_Cell_Surface/geneticsFemalePromoter_Regions,_Genetic
copydeleteadd this publication to your clipboard
1Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction
A. Antoniou, J. Beesley, L. McGuffog, O. Sinilnikova, S. Healey, S. Neuhausen, Y. Ding, T. Rebbeck, J. Weitzel, H. Lynch and 168 other author(s). Cancer research, 70 (23): 9742–9754 (2010)
10 years ago by @drtester
show all tags
Middle_Aged
Humans
Vesicular_Transport_Proteins/genetics
Genotype
Polymorphism,_Single_Nucleotide
Risk_Factors
BRCA1_Protein/genetics
Receptors,_Progesterone/genetics
Risk_Assessment
Aged,_80_and_over
Sodium-Bicarbonate_Symporters/genetics
Alleles
Genetic_Predisposition_to_Disease/genetics
Heterozygote
Adult
Mutation
Aged
Breast_Neoplasms/genetics/pathology
Survival_Analysis
BRCA2_Protein/genetics
Female
Middle_AgedHumansVesicular_Transport_Proteins/geneticsGenotypePolymorphism,_Single_NucleotideRisk_FactorsBRCA1_Protein/geneticsReceptors,_Progesterone/geneticsRisk_AssessmentAged,_80_and_overSodium-Bicarbonate_Symporters/geneticsAllelesGenetic_Predisposition_to_Disease/geneticsHeterozygoteAdultMutationAgedBreast_Neoplasms/genetics/pathologySurvival_AnalysisBRCA2_Protein/geneticsFemale
copydeleteadd this publication to your clipboard
1Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers
A. Antoniou, C. Kartsonaki, O. Sinilnikova, P. Soucy, L. McGuffog, S. Healey, A. Lee, P. Peterlongo, S. Manoukian, B. Peissel and 169 other author(s). Human molecular genetics, 20 (16): 3304–3321 (2011)
10 years ago by @drtester
show all tags
Middle_Aged
Chromosomes,_Human/genetics
Humans
Risk_Factors
Chromosomes,_Human,_Pair_6/genetics
BRCA1_Protein/genetics
Polymorphism,_Single_Nucleotide/genetics
Chromosomes,_Human,_Pair_1/genetics
Genetic_Predisposition_to_Disease
Alleles
Breast_Neoplasms/genetics
Heterozygote
Mutation/genetics
Adult
Aged
BRCA2_Protein/genetics
Female
Middle_AgedChromosomes,_Human/geneticsHumansRisk_FactorsChromosomes,_Human,_Pair_6/geneticsBRCA1_Protein/geneticsPolymorphism,_Single_Nucleotide/geneticsChromosomes,_Human,_Pair_1/geneticsGenetic_Predisposition_to_DiseaseAllelesBreast_Neoplasms/geneticsHeterozygoteMutation/geneticsAdultAgedBRCA2_Protein/geneticsFemale
copydeleteadd this publication to your clipboard
1Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts
Vasen, Hans F A, I. Blanco, K. Aktan-Collan, J. Gopie, A. Alonso, S. Aretz, I. Bernstein, L. Bertario, J. Burn, G. Capella and 26 other author(s). Gut, 62 (6): 812–823 (2013)
10 years ago by @drtester
show all tags
Middle_Aged
Colorectal_Neoplasms,_Hereditary_Nonpolyposis/complications/diagnosis/genetics/therapy
Public_Health_Surveillance
Young_Adult
Colonoscopy/standards
Humans
Male
Neoplasms/diagnosis/etiology/genetics/therapy
Adult
Aged
Risk_Factors
Female
Middle_AgedColorectal_Neoplasms,_Hereditary_Nonpolyposis/complications/diagnosis/genetics/therapyPublic_Health_SurveillanceYoung_AdultColonoscopy/standardsHumansMaleNeoplasms/diagnosis/etiology/genetics/therapyAdultAgedRisk_FactorsFemale
copydeleteadd this publication to your clipboard

⟨⟨
⟨
1
2
3
⟩
⟩⟩

publications (hide)45 displayallpublications onlypublications per page5102050100 sort byadded attitleauthorpublication dateentry typehelp for advanced sorting... RSSBibTeXRDFmore...

related tags

tags

publications (hide)45
display
all
publications only
publications per page
5
10
20
50
100
sort by
added at
title
author
publication date
entry type
help for advanced sorting...
RSS
BibTeX
RDF
more...